NAD+, MOTS-c and SS-31 get shelved together because all three are studied in mitochondrial biology. That is the only thing they have in common. One is a dinucleotide coenzyme that has been in biochemistry textbooks for a century. One is a peptide encoded inside mitochondrial DNA and only described in 2015. One is a synthetic tetrapeptide designed to concentrate at the inner mitochondrial membrane. Different molecules, different literatures, different handling.
NAD+ is a coenzyme, not a peptide
NAD+, nicotinamide adenine dinucleotide, is two nucleotides joined through their phosphate groups. It has no amino acids and no peptide bonds, and calling it a peptide is simply a category error. Its role is redox chemistry: it cycles between the oxidized form NAD+ and the reduced form NADH, carrying electrons through glycolysis, the citric acid cycle and oxidative phosphorylation.
The reason it appears in mitochondrial research is the second role. NAD+ is consumed as a substrate, not merely cycled, by sirtuins and by PARP enzymes. Every sirtuin deacetylation reaction cleaves an NAD+ molecule. That makes cellular NAD+ availability a control point linking metabolic state to protein deacetylation and DNA-damage response, which is the axis most NAD+ work in aging models is built around. Reported declines in tissue NAD+ with age in animal models are the starting observation for much of that field.
MOTS-c is encoded inside the mitochondrial genome
MOTS-c is a peptide of sixteen amino acids whose open reading frame sits within the 12S ribosomal RNA gene of mitochondrial DNA. That is the structurally interesting part. Mitochondria were known to encode thirteen proteins of the respiratory chain, and the identification of small peptides encoded in the same genome, with signaling roles outside the organelle, opened a distinct class known as mitochondrial-derived peptides.
The 2015 report that introduced it described regulation of folate and methionine cycle metabolism, accumulation of the intermediate AICAR and consequent activation of AMP-activated protein kinase, with metabolic phenotypes in mouse models. Later work has examined nuclear translocation under metabolic stress and binding at antioxidant response elements, which is why MOTS-c is now described as retrograde signaling from the mitochondrion to the nucleus. Preclinical models only.
SS-31 is a synthetic tetrapeptide that binds cardiolipin
SS-31, also called elamipretide, is four residues long, D-Arg-dimethylTyr-Lys-Phe-amide. The alternating cationic and aromatic pattern belongs to the Szeto-Schiller series, which was designed to be cell-permeable and to accumulate at the inner mitochondrial membrane independently of membrane potential. Membrane-potential independence is the notable design feature, since damaged mitochondria with collapsed potential are exactly the ones that resist potential-driven targeting.
The binding partner is cardiolipin, the four-tailed phospholipid essentially unique to the inner mitochondrial membrane. Cardiolipin organizes cristae curvature and holds respiratory-chain supercomplexes together, and it also binds cytochrome c. SS-31 is studied as a modifier of that interaction, with published work reporting effects on cristae architecture, supercomplex assembly and the peroxidase behavior of the cytochrome c and cardiolipin complex in isolated mitochondria and cell models.
Side by side
| Attribute | NAD+ | MOTS-c | SS-31 |
|---|---|---|---|
| Chemical class | Dinucleotide coenzyme | Peptide, 16 residues | Peptide, 4 residues, amidated |
| Origin | Endogenous metabolite | Encoded in mitochondrial 12S rRNA | Wholly synthetic design |
| First described as such | Early twentieth century | 2015 | Early 2000s |
| Proposed point of action | Redox cycling, sirtuin and PARP substrate | AMPK axis, nuclear retrograde signaling | Cardiolipin at the inner membrane |
| Typical model systems | Cell culture, rodent aging and metabolic models | Mouse metabolic models, myoblast culture | Isolated mitochondria, ischemia-reperfusion and renal models |
| Analytical method for purity | HPLC for a small molecule, different wavelength | Peptide HPLC with mass-spec identity | Peptide HPLC with mass-spec identity |
Handling differences that matter
These three do not behave the same on the bench. NAD+ is hygroscopic and unstable in aqueous solution, particularly at alkaline pH, and it degrades faster at room temperature than either peptide. Solutions are made fresh and kept cold and dark, and repeated freeze-thaw is best avoided. Because it is not a peptide, its chromatogram and detection wavelength differ from the peptide standard, so a purity figure for NAD+ should not be compared line for line with one from a peptide certificate. Our article on what HPLC purity measures explains why the method has to match the analyte.
MOTS-c is a conventional lyophilized peptide and follows ordinary peptide practice: gentle reconstitution down the vial wall, no shaking, cold storage after reconstitution and aliquoting before any freeze. SS-31 is short, amidated and built partly from D-amino acids and non-standard residues, which makes it comparatively robust against proteolysis, but it is still handled as a peptide once in solution. The arithmetic for all three is the same, and it is set out in our reconstitution guide. Storage windows are covered in the stability guide.
Running them as a set
Laboratories that want to compare a substrate-availability model, a genome-encoded signaling model and a membrane-targeting model in the same system often want all three vials at once with matched lots. That is what the NAD Stack bundle is for. The rest of the individually available compounds sit in the peptide catalog, each with its own lot certificate.
The coenzyme itself, its redox pair, its sirtuin and PARP substrates and the handling that follows from its light sensitivity are covered in depth in what is NAD+.
Frequently asked questions
Is MOTS-c related to NAD+ biology?
Indirectly. Both are discussed in relation to AMP-activated protein kinase and cellular energy sensing, and both appear in metabolic and aging literature. They are separate molecules acting through separate mechanisms, and no established pathway makes one dependent on the other.
Why is SS-31 targeted without relying on membrane potential?
Because it binds cardiolipin, a lipid that is concentrated in the inner mitochondrial membrane regardless of the potential across that membrane. Potential-driven targeting fails in depolarized mitochondria, which are often the ones a study is interested in.
Can NAD+ purity be compared with peptide purity?
Not directly. The analyte is a nucleotide, so the chromatographic method and detection wavelength differ. Compare an NAD+ certificate against other NAD+ certificates, and check that the method is stated.
References
- Zhao and colleagues, 2004, Journal of Biological Chemistry, Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling and oxidative cell death.
- Birk and colleagues, 2013, Journal of the American Society of Nephrology, The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin.
- Lee and colleagues, 2015, Cell Metabolism, The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.
- Verdin, 2015, Science, NAD+ in aging, metabolism, and neurodegeneration.
Research use only. This article describes laboratory and preclinical research. Homegrown Peptides products are not for human or animal use, are not drugs, and are not intended to diagnose, treat, cure or prevent any disease. Nothing here is medical advice or a protocol.
